ArticleLeukemia2012
KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib.
D Marin et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papertrialcites it